SLC2A3 and cancer: found that overexpression of miR-106a downregulated expression of glucose transporter 3 (GLUT3) or SLC2A3, an oncogene in several human cancers, via targeting 3′ UTR of SLC2A3, resulted in suppression of cell proliferation and cell glucose uptake in GBM cells.60